Biogen
BIIB
#870
Rank
ยฃ18.00 B
Marketcap
ยฃ123.55
Share price
0.06%
Change (1 day)
-32.83%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Revenue for Biogen (BIIB)

Revenue in 2024 (TTM): ยฃ7.70 Billion

According to Biogen's latest financial reports the company's current revenue (TTM ) is ยฃ7.65 Billion. In 2023 the company made a revenue of ยฃ7.72 Billion a decrease over the revenue in the year 2022 that were of ยฃ8.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Biogen from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ7.70 B-0.13%
2023 ยฃ7.72 B-8.19%
2022 ยฃ8.40 B3.36%
2021 ยฃ8.13 B-17.52%
2020 ยฃ9.86 B-10.04%
2019 ยฃ10.96 B3.46%
2018 ยฃ10.59 B16.7%
2017 ยฃ9.08 B-2.12%
2016 ยฃ9.27 B27.74%
2015 ยฃ7.26 B16.54%
2014 ยฃ6.23 B48.3%
2013 ยฃ4.20 B6.58%
2012 ยฃ3.94 B28.16%
2011 ยฃ3.07 B0.7%
2010 ยฃ3.05 B12.95%
2009 ยฃ2.70 B-3.24%
2008 ยฃ2.79 B75.12%
2007 ยฃ1.59 B67.03%
2006 ยฃ0.95 B-3.82%
2005 ยฃ0.99 B19.55%
2004 ยฃ0.83 B2012.31%
2003 ยฃ39.35 M-94.51%
2002 ยฃ0.71 B-0.47%
2001 ยฃ0.71 B15.92%
2000 ยฃ0.62 B26.26%
1999 ยฃ0.49 B46.61%
1998 ยฃ0.33 B26.94%
1997 ยฃ0.26 B63.18%
1996 ยฃ0.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ25.75 B 236.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ22.00 B 187.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ43.53 B 468.65%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.04 B 475.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ69.41 B 806.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ91.55 M-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.35 B 453.22%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ2.04 B-73.32%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.50 B-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.53 B-79.94%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands